The pipeline of investigational therapies for hereditary angioedema (HAE) includes both novel inhibitors of known molecular targets and more ambitious gene editing-based approaches. Selected agents ...
Icatibant is a generic drug that is given as an injection under the skin to treat sudden attacks of hereditary angioedema (HAE) in adults. It starts working to improve your symptoms soon after you ...
RAPIDe-3 met the primary and all 11 secondary efficacy endpoints with high statistical significance with deucrictibant achieving onset of symptom relief in 1.28 hours and complete symptom resolution ...
Hereditary angioedema is a potentially life-threatening autosomal dominant condition, causing attacks of angioedema due to failure to regulate bradykinin. Nearly all cases of hereditary angioedema are ...
The goal of acute treatment of an hereditary angioedema (HAE) attack is to reduce its duration and severity and thus limit its impact on the patient’s functional ability and prevent a potentially ...
A person with hereditary angioedema (HAE) should seek emergency care during an HAE episode if they are having difficulty breathing or experiencing swelling of the tongue or throat, which could lead to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results